Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-011366
Filing Date
2025-03-07
Accepted
2025-03-07 17:15:51
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cpix-20241231.htm   iXBRL 10-K 1742147
2 EX-3.1 ex31forthamendedcharter.htm EX-3.1 61642
3 EX-10.11 ex1011-ajkazimixemployment.htm EX-10.11 39965
4 EX-10.12 ex1012-jimhermanxemploymen.htm EX-10.12 40522
5 EX-10.13 ex1013-toddanthonyxemploym.htm EX-10.13 39684
6 EX-10.14 ex1014-chrisbittermanxempl.htm EX-10.14 39951
7 EX-10.15 ex1015-johnhammxemployment.htm EX-10.15 39222
8 EX-19 ex19-insidertradingpolicy.htm EX-19 5529
9 EX-23.1 a2312024consentofaccountin.htm EX-23.1 2235
10 EX-31.1 a2024-10kxexhibit311.htm EX-31.1 12787
11 EX-31.2 a2024-10kxexhibit312.htm EX-31.2 12259
12 EX-32.1 a2024-10kxexhibit321.htm EX-32.1 6518
18 cpix-20241231_g1.jpg GRAPHIC 108927
  Complete submission text file 0001628280-25-011366.txt   9767946

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20241231.xsd EX-101.SCH 74671
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20241231_cal.xml EX-101.CAL 89026
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20241231_def.xml EX-101.DEF 280470
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20241231_lab.xml EX-101.LAB 831451
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20241231_pre.xml EX-101.PRE 569944
117 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20241231_htm.xml XML 1149505
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 25721234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)